Spruce Biosciences Inc. (SPRB)
NASDAQ: SPRB
· Real-Time Price · USD
8.75
-0.55 (-5.93%)
At close: Jun 09, 2025, 3:57 PM
8.75
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT
Spruce Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 697K | 602K | 1.61M | 2M | 2.89M | 3.07M | 2.17M | 1.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 16K | 17K | 74K | 77K | 129K | 107K | 9.06M | 103K | 88K | 96K | 95K | 90K |
Gross Profit | n/a | 697K | 602K | 1.61M | 2M | 2.87M | 3.06M | 2.09M | 1.89M | -129K | -107K | -9.06M | -103K | -88K | -96K | -95K | -90K |
Operating Income | -14.49M | -24.07M | -9.41M | -10.04M | -12.63M | -11.16M | -13.66M | -13.97M | -13.2M | -12.11M | -11.56M | -11.88M | -11.73M | -9.13M | -11.4M | -11.71M | -9.82M |
Interest Income | 487K | 571K | 808K | 938K | 1.1M | 1.32M | 1.42M | 1.27M | 539K | 1.09M | 266K | 104K | 58K | n/a | 41K | n/a | n/a |
Pretax Income | -14.04M | -23.56M | -8.67M | -9.18M | -11.63M | -9.95M | -12.35M | -12.82M | -12.79M | -11.14M | -11.4M | -11.87M | -11.76M | -9.18M | -11.45M | -11.77M | -9.89M |
Net Income | -14.04M | -23.56M | -8.67M | -9.18M | -11.63M | -9.95M | -12.35M | -12.82M | -12.79M | -10.2M | -11.24M | -11.87M | -11.79M | -9.18M | -11.45M | -11.77M | -9.89M |
Selling & General & Admin | 3.65M | 3.31M | 3.46M | 3.56M | 4.32M | 2.95M | 3.24M | 3.01M | 3.45M | 3.27M | 2.77M | 2.82M | 3.23M | 2.88M | 2.79M | 2.6M | 3.1M |
Research & Development | 10.84M | 21.46M | 6.55M | 8.09M | 10.32M | 11.1M | 13.49M | 13.13M | 11.71M | 8.84M | 8.79M | 9.06M | 8.51M | 6.26M | 8.61M | 9.12M | 6.71M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 104K | 58K | 39K | 41K | 20K | 19K |
Operating Expenses | 14.49M | 24.77M | 10.01M | 11.65M | 14.63M | 14.05M | 16.73M | 16.14M | 15.16M | 12.11M | 11.56M | 11.88M | 11.73M | 9.13M | 11.4M | 11.71M | 9.82M |
Interest Expense | 36K | 56K | 71K | 83K | 97K | 106K | 119K | 127K | 131K | 129K | 110K | 94K | 87K | 88K | 88K | 80K | 89K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 14.49M | 24.77M | 10.01M | 11.65M | 14.63M | 14.05M | 16.73M | 16.14M | 15.16M | 12.11M | 11.56M | 11.88M | 11.73M | 9.13M | 11.4M | 11.71M | 9.82M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -17K | n/a | n/a | -947K | -156K | n/a | 29K | n/a | n/a | 100K | n/a |
Shares Outstanding (Basic) | 571.28K | 536.44K | 536.93K | 535.12K | 534.25K | 533.39K | 529.24K | 527.12K | 414.7K | 612.64K | 612.57K | 610.83K | 610.8K | 609.8K | 607.55K | 606.57K | 605.38K |
Shares Outstanding (Diluted) | 571.28K | 536.44K | 536.93K | 535.12K | 534.25K | 533.39K | 529.24K | 527.12K | 414.7K | 612.64K | 612.57K | 610.83K | 610.8K | 609.8K | 607.55K | 606.57K | 605.38K |
EPS (Basic) | -24 | -42.75 | -15.75 | -16.5 | -21 | -18 | -22.5 | -24 | -29.25 | -16.5 | -18 | -18.75 | -18.75 | -15 | -18 | -18.75 | -15.75 |
EPS (Diluted) | -24 | -42.75 | -15.75 | -16.5 | -21 | -18 | -22.5 | -24 | -29.25 | -16.5 | -18 | -18.75 | -18.75 | -15 | -18 | -18.75 | -15.75 |
EBITDA | -14M | -23.49M | -8.59M | -9.09M | -11.51M | -9.83M | -12.22M | -12.62M | -12.58M | -10.89M | -11.18M | -11.69M | -11.57M | -9.01M | -11.26M | -11.6M | -9.71M |
EBIT | -14.01M | -23.5M | -8.6M | -9.1M | -11.53M | -9.84M | -12.23M | -12.7M | -12.66M | -11.02M | -11.29M | -11.78M | -11.68M | -9.1M | -11.36M | -11.69M | -9.8M |
Depreciation & Amortization | 6K | 9K | 10K | 12K | 15K | 16K | 17K | 74K | 77K | 129K | 107K | 90K | 103K | 88K | 96K | 95K | 90K |